Key Points

HIV Infections and AIDS

• The completeness of mandatory HIV reporting (DO) improved in French Guiana in 2023 but remains insufficient to reliably estimate the rate of new HIV diagnoses and to describe the characteristics of people diagnosed in the territory.

• All laboratories in French Guiana participated in the LaboVIH survey in 2023.

• The HIV testing rate in French Guiana increased in 2023 and is the highest in the country. The lowest testing rate is among men aged 15 to 24.

• Although it is not possible to reliably estimate the number of new HIV diagnoses, the number of new HIV cases is slightly decreasing in 2023. A downward trend in the number of new diagnoses is also observed among individuals receiving hospital care (data from COREVIH).

• According to the LaboVIH survey, the rate of confirmed positive serology results decreased in 2023 while the screening rate increased, which supports a downward trend in positive serology results.

• In 2023, no mandatory AIDS case reports were filed in French Guiana. Among patients currently under care at French Guiana’s hospitals, COREVIH recorded 10 patients who progressed to the AIDS stage in 2023.

Chlamydia trachomatis (Ct), gonorrhea, and syphilis infections

• Screening rates for Ct, gonorrhea, and syphilis infections increased slightly in French Guiana in 2023 and are more than twice as high as those observed at the national level.

• Screening for Ct, gonorrhea, and syphilis infections primarily involves women aged 26 to 49. Men aged 15 to 25 are the least likely to be screened.

• Diagnosis rates for Chlamydia, gonorrhea, and syphilis are generally on the rise in French Guiana in 2023. However, there is a decline in syphilis diagnoses among men aged 26 to 49 and in Chlamydia infections among men aged 15 to 25.

• The highest rates of diagnosis for Chlamydia, gonorrhea, and syphilis infections are observed among women aged 15 to 25, followed by women aged 26 to 49.

• All four CeGiDDs in French Guiana submitted their data in 2023 as part of the SurCeGIDD surveillance program. The majority of cases who sought care at a CeGIDD for Chlamydia, gonorrhea, or syphilis were under 26 years of age and were mostly born abroad.